...
首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases
【24h】

GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases

机译:GSK3和神经组织中的miRNA:从脑发育到神经变性疾病

获取原文
获取原文并翻译 | 示例

摘要

MicroRNAs (miRs) are small RNAs modulating gene expression and creating intricate regulatory networks that are dysregulated in many pathological states, including neurodegenerative disorders. In silico analyses denote a multifunctional kinase glycogen synthase kinase-3 (GSK3) as a putative target of numerous miRs identified in neural tissue. GSK3 is engaged in almost all aspects of neuronal development and functioning. Moreover, there is an autoregulatory feedback between GSK3 and miRNAs as the kinase can influence biogenesis of miRs. Members of the miR-GSK3 axes might thus represent convenient therapeutic targets in neuropathologies that display its abnormal regulation. This review summarizes the present knowledge about direct interactions of GSK3 and miRs in brain, and their putative roles in pathogenesis of neurodegenerative and neuropsychiatric disorders. This article is part of a Special Issue entitled: GSK-3 and related kinases in cancer, neurological and other disorders edited by James McCubrey, Agnieszka Gizak and Dariusz Rakus.
机译:MicroRNA(MIRS)是小RNA调节基因表达,并产生复杂的调节网络,这些网络在许多病理状态中具有吸诵,包括神经变性障碍。在硅分析中,将多官能激酶糖原合酶激酶-3(GSK3)表示为在神经组织中鉴定的许多MIR的推定靶标。 GSK3从事神经元发展和功能的几乎所有方面。此外,随着激酶可以影响MIR的生物发生,GSK3和MIRNA之间存在自动调节反馈。因此,MIR-GSK3轴的成员可能在显示其异常调节的神经病理学中的方便治疗靶标。本综述总结了关于GSK3和大脑中GSK3和MIRS的直接相互作用的知识,以及它们在神经变性和神经精神障碍发病机制中的推定作用。本文是题为的特殊问题的一部分:James McCubrey,Agnieszka Gizak和Dariusz Rakus编辑的癌症,神经系统和其他疾病中的GSK-3和相关激酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号